Biotech Values

[Double_Bagel]

I guess one of these is now ruled out

Bullish things for MNTA that could happen at almost any time:

• FDA tentative approval of MNTA’s Copaxone ANDA (i.e. FDA approval with effective date at expiration of Teva’s Orange Book patents in 2014).

• A partnership deal for M402.

• A settlement of the Lovenox patent case.

• Disclosures re first two compounds in FoB program with BAX.

• Monetization of MNTA’s Lovenox royalty stream.

• A buyout offer from BAX, NVS, or someone else.